SarcoglycansTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningSarcoma 180Transplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationStem CellsTransplantation ChimeraBone Marrow TransplantationGraft vs Leukemia EffectTissue DonorsMyeloablative AgonistsGraft SurvivalBusulfanTreatment OutcomeVidarabineRemission InductionRecurrenceGraft vs Tumor EffectHistocompatibility TestingCord Blood Stem Cell TransplantationLymphocyte TransfusionWhole-Body IrradiationLeukemiaLeukemia, Myeloid, AcuteImmunosuppressive AgentsHematopoietic Stem Cell MobilizationMultiple MyelomaRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSiblingsCombined Modality TherapyAntigens, CD34Cytomegalovirus InfectionsHistocompatibilityMinor Histocompatibility AntigensLymphocyte DepletionSalvage TherapyMyelodysplastic SyndromesChimerismDisease-Free SurvivalAntilymphocyte SerumSurvival AnalysisSurvival RateLiver TransplantationMesenchymal Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaVirus ActivationNeoplasm, ResidualMelphalanTime FactorsHepatic Veno-Occlusive DiseaseCyclophosphamideT-LymphocytesAdult Stem CellsBone Marrow CellsHematopoiesisCell TransplantationAntineoplastic Combined Chemotherapy ProtocolsAnemia, AplasticCytomegalovirusHLA AntigensHematologic DiseasesAcute DiseasePrimary MyelofibrosisCell DifferentiationEmbryonic Stem CellsTransplantation ImmunologyFlow CytometryFollow-Up StudiesGranulocyte Colony-Stimulating FactorStem Cell NicheKidney TransplantationImmunosuppressionPrognosisBone MarrowLeukemia, Myeloid, Accelerated PhaseLeukemia, MyeloidRoseolovirus InfectionsImmunocompromised HostAntibodies, NeoplasmCytarabineCell LineageLymphoproliferative DisordersMice, Inbred C57BLBenzamidesGraft RejectionAntineoplastic AgentsPluripotent Stem CellsFusion Proteins, bcr-ablCells, CulturedFetal BloodMesenchymal Stromal CellsTransplantation, IsogeneicHodgkin DiseasePyrimidinesNuclear Family